Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach

Author：

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.29, Iss.5, 2012-01, pp. : 832-840

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 662-675

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biomarker Studies on Radiotherapy to Hepatocellular Carcinoma

Oncology, Vol. 84, Iss. 1, 2013-02 ,pp. : 64-68

Karger

Access to resources Recommend Favorite

TPX2 as a novel prognostic biomarker for hepatocellular carcinoma

HEPATOLOGY RESEARCH, Vol. 45, Iss. 8, 2015-08 ,pp. : 906-918

John Wiley & Sons Inc

Access to resources Recommend Favorite

Identification of an Oligopeptide Binding to Hepatocellular Carcinoma

Oncology, Vol. 71, Iss. 1-2, 2007-04 ,pp. : 136-145

Karger

Access to resources Recommend Favorite

A knowledge‐based approach to automated planning for hepatocellular carcinoma

Journal of Applied Clinical Medical Physics, Vol. 19, Iss. 1, 2018-01 ,pp. : 50-59

John Wiley & Sons Inc

Access to resources Recommend Favorite